Completed
A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers
NCT01107054
- Conditions
- Lung Disease, Lung Diseases, Moxifloxacin, +2 more
- Locations
-
- Pfizer Investigational Site Brussels, Belgium